where to inject semaglutide stomach Semaglutide: Optimal Sites for Maximum Efficacy Semaglutide for Weight Loss in

A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

10.1002/jnr.10439 J Neurosci Res

Incorrect administration reduces absorption and may reduce the effectiveness of the medication

Members must also continue to take the maximized statin treatment regimen during treatment with the non-preferred lipotropics, omega-3 acid

Patients should be counselled about the likelihood of nausea, particularly during the initial weeks of Saxenda therapy, and advised on strategies to minimise discomfort, such as eating smaller, more frequent meals and staying well hydrated